Uso do composto ativado por akr1c3
uso do composto ativado por akr1c3. a presente invenção refere-se ao uso médico do composto 1-(3-(3-n,n-dimetilaminocarbonil)fenoxil-4-mtrofenil)-1-etil-n,n'-bis(etileno)fosforami-dato, ou um sal farmaceuticamente aceitável, variante isotópica ou solvato do mesmo, e a uma composição que compree...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JIANXIN DUAN WAN-FEN LI FANYING MENG LU-TZU CHEN MING-TAIN LAI TIANYANG QI CHUNUNG WANG |
| description | uso do composto ativado por akr1c3. a presente invenção refere-se ao uso médico do composto 1-(3-(3-n,n-dimetilaminocarbonil)fenoxil-4-mtrofenil)-1-etil-n,n'-bis(etileno)fosforami-dato, ou um sal farmaceuticamente aceitável, variante isotópica ou solvato do mesmo, e a uma composição que compreende o composto acima e pelo me-nos um fármaco anticancerígeno e seu uso médico.
Provided are the use of the compound 1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-mtrophenyl)-1-ethyl-N,N′-bis(ethylene)phosphoramidate, or a pharmaceutically acceptable salt, isotopic variant or solvate thereof in the manufacture of a medicament for treating cancer, and a composition which comprises the above compound and at least one anti-cancer drug. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112023017126A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112023017126A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112023017126A23</originalsourceid><addsrcrecordid>eNrjZFAKLc5XSMlXSM7PLcgvLslXSCzJLEsEChTkFykkZhcZJhvzMLCmJeYUp_JCaW4GVTfXEGcP3dSC_PjU4oLE5NS81JJ4pyBDQyMDI2MDQ3NDIzNHI2Ni1QEAmLkm6w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Uso do composto ativado por akr1c3</title><source>esp@cenet</source><creator>JIANXIN DUAN ; WAN-FEN LI ; FANYING MENG ; LU-TZU CHEN ; MING-TAIN LAI ; TIANYANG QI ; CHUNUNG WANG</creator><creatorcontrib>JIANXIN DUAN ; WAN-FEN LI ; FANYING MENG ; LU-TZU CHEN ; MING-TAIN LAI ; TIANYANG QI ; CHUNUNG WANG</creatorcontrib><description>uso do composto ativado por akr1c3. a presente invenção refere-se ao uso médico do composto 1-(3-(3-n,n-dimetilaminocarbonil)fenoxil-4-mtrofenil)-1-etil-n,n'-bis(etileno)fosforami-dato, ou um sal farmaceuticamente aceitável, variante isotópica ou solvato do mesmo, e a uma composição que compreende o composto acima e pelo me-nos um fármaco anticancerígeno e seu uso médico.
Provided are the use of the compound 1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-mtrophenyl)-1-ethyl-N,N′-bis(ethylene)phosphoramidate, or a pharmaceutically acceptable salt, isotopic variant or solvate thereof in the manufacture of a medicament for treating cancer, and a composition which comprises the above compound and at least one anti-cancer drug.</description><language>por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231212&DB=EPODOC&CC=BR&NR=112023017126A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231212&DB=EPODOC&CC=BR&NR=112023017126A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JIANXIN DUAN</creatorcontrib><creatorcontrib>WAN-FEN LI</creatorcontrib><creatorcontrib>FANYING MENG</creatorcontrib><creatorcontrib>LU-TZU CHEN</creatorcontrib><creatorcontrib>MING-TAIN LAI</creatorcontrib><creatorcontrib>TIANYANG QI</creatorcontrib><creatorcontrib>CHUNUNG WANG</creatorcontrib><title>Uso do composto ativado por akr1c3</title><description>uso do composto ativado por akr1c3. a presente invenção refere-se ao uso médico do composto 1-(3-(3-n,n-dimetilaminocarbonil)fenoxil-4-mtrofenil)-1-etil-n,n'-bis(etileno)fosforami-dato, ou um sal farmaceuticamente aceitável, variante isotópica ou solvato do mesmo, e a uma composição que compreende o composto acima e pelo me-nos um fármaco anticancerígeno e seu uso médico.
Provided are the use of the compound 1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-mtrophenyl)-1-ethyl-N,N′-bis(ethylene)phosphoramidate, or a pharmaceutically acceptable salt, isotopic variant or solvate thereof in the manufacture of a medicament for treating cancer, and a composition which comprises the above compound and at least one anti-cancer drug.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAKLc5XSMlXSM7PLcgvLslXSCzJLEsEChTkFykkZhcZJhvzMLCmJeYUp_JCaW4GVTfXEGcP3dSC_PjU4oLE5NS81JJ4pyBDQyMDI2MDQ3NDIzNHI2Ni1QEAmLkm6w</recordid><startdate>20231212</startdate><enddate>20231212</enddate><creator>JIANXIN DUAN</creator><creator>WAN-FEN LI</creator><creator>FANYING MENG</creator><creator>LU-TZU CHEN</creator><creator>MING-TAIN LAI</creator><creator>TIANYANG QI</creator><creator>CHUNUNG WANG</creator><scope>EVB</scope></search><sort><creationdate>20231212</creationdate><title>Uso do composto ativado por akr1c3</title><author>JIANXIN DUAN ; WAN-FEN LI ; FANYING MENG ; LU-TZU CHEN ; MING-TAIN LAI ; TIANYANG QI ; CHUNUNG WANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112023017126A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JIANXIN DUAN</creatorcontrib><creatorcontrib>WAN-FEN LI</creatorcontrib><creatorcontrib>FANYING MENG</creatorcontrib><creatorcontrib>LU-TZU CHEN</creatorcontrib><creatorcontrib>MING-TAIN LAI</creatorcontrib><creatorcontrib>TIANYANG QI</creatorcontrib><creatorcontrib>CHUNUNG WANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JIANXIN DUAN</au><au>WAN-FEN LI</au><au>FANYING MENG</au><au>LU-TZU CHEN</au><au>MING-TAIN LAI</au><au>TIANYANG QI</au><au>CHUNUNG WANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Uso do composto ativado por akr1c3</title><date>2023-12-12</date><risdate>2023</risdate><abstract>uso do composto ativado por akr1c3. a presente invenção refere-se ao uso médico do composto 1-(3-(3-n,n-dimetilaminocarbonil)fenoxil-4-mtrofenil)-1-etil-n,n'-bis(etileno)fosforami-dato, ou um sal farmaceuticamente aceitável, variante isotópica ou solvato do mesmo, e a uma composição que compreende o composto acima e pelo me-nos um fármaco anticancerígeno e seu uso médico.
Provided are the use of the compound 1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-mtrophenyl)-1-ethyl-N,N′-bis(ethylene)phosphoramidate, or a pharmaceutically acceptable salt, isotopic variant or solvate thereof in the manufacture of a medicament for treating cancer, and a composition which comprises the above compound and at least one anti-cancer drug.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR112023017126A2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Uso do composto ativado por akr1c3 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T16%3A19%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JIANXIN%20DUAN&rft.date=2023-12-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112023017126A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |